NCT01363453已完成不适用
Acute and Remission Therapy of Ulcerative Colitis With Oral Mesalazine
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 500
- 试验地点
- 105
- 主要终点
- Prescription habits measured by daily dose of Mesalazine
研究概览
简要总结
The aim of the non-interventional study is to document the daily doses in acute and remission therapy, the frequence of doses (1, 2, 3 or 4 times daily), when rectal dosage forms are added and, when and how long steroids are given.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •therapeutic need according to SPC
- •written informed consent
排除标准
- •contraindications according to SPC
结局指标
主要结局
Prescription habits measured by daily dose of Mesalazine
时间窗: 0 - 8 weeks
次要结局
- Compliance measured by questionnaire for drug intake(0 - 8 weeks)
- Quality of Life measured by EuroQol Questionnaire(0 - 8 weeks)
研究者
研究点 (105)
Loading locations...
相似试验
终止
不适用
Use of the Ulcerative Colitis Diet for Induction of RemissionUlcerative Colitis (UC)NCT02217722Prof. Arie Levine9
已完成
3 期
A Comparison of Once a Day Dose Compared to 2 Doses/DayUlcerative ColitisNCT00505778Warner Chilcott1,027
已完成
不适用
Study to Assess Effectiveness of Therapy Timely Adjustment Based on Self-monitoring in Patients Suffering From Mild-to-moderate Ulcerative Colitis (OPTIMISE Study)Mild-to-moderate Ulcerative ColitisNCT04340895Ferring Pharmaceuticals250
终止
2 期
Antimicrobial Therapy for Ulcerative Colitis (UC)Ulcerative ColitisNCT03986996Wolfson Medical Center20
已完成
3 期
Mesalamine Pellet to Maintain Remission of Mild to Moderate Ulcerative ColitisUlcerative ColitisNCT00767728Bausch Health Americas, Inc.256